SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gilead Science (GILD) Followers
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
961 87 0 GILD
Emcee:  SybilNicolas Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
411 I must say, as a physician, the results look spectacular. What I like best aboDoug Meetmer-9/29/1997
410 Here it IS!!! biz.yahoo.com And it really looks terrific. A lot of the prictdinovo-9/29/1997
409 Patric: Flu vaccine will continue to play significant rule in therapy during *Miljenko Zuanic-9/27/1997
408 Pat; Wednesday,oct.1 at 12:30..Presenter is Hayden FG...Rm718A/B best of luck tsaadi taher-9/27/1997
407 Tom, thanks for your response. PatPatrick E.McDaniel-9/27/1997
406 Zanamivir is of only marginal value. Fevers are not unusual on the first day oTom D-9/27/1997
405 Miljenko, what is the significance of this competition for GILD? yahoo.com DoPatrick E.McDaniel-9/27/1997
404 tdinovo: It's interesting that three of us that tasted AMGN and bailed earscaram(o)uche-9/26/1997
403 Rich, This is d‚j… vu all over again. I also became interested in GILD in 1tdinovo-9/26/1997
402 Speaking of questionable analysts reports -- today Morgan Stanley downgraded CyStarlight-9/26/1997
401 MZ: An assortment of beverages rather than inhalers. Let's turn that two scaram(o)uche-9/25/1997
400 Glaxo open his cards (two pairs)! reutershealth.com Let see what GILD *zanamiMiljenko Zuanic-9/25/1997
399 <<Geron wasn't so lucky>> GERN will have a product on the markeT. Mann-9/24/1997
398 Geron wasn't so lucky. AVIR is breaking down right now. and a month fromTrey Yon-9/24/1997
397 Trey: You are very wrong. Flu season just started and Roche, remember Roche, Miljenko Zuanic-9/23/1997
396 Trey, <Buy the Rumor, Sell the News>. I remember what happened to AVIR whT. Mann-9/23/1997
395 I think the people at Vector are on the mark; use the conference news as an oppTrey Yon-9/23/1997
394 John: Agree. This is, IMO, technical move by Michael K. To be ahead of the evMiljenko Zuanic-9/23/1997
393 Thanks, Betty. We've all seen questionable practices amongst analysts and John Metcalf-9/23/1997
392 Miljenko, Zavamivir sounds like a good name for GS4104. :-) T.T. Mann-9/23/1997
391 Sorry - I wasn't familiar with Vector. I've seen companies get downgraStarlight-9/23/1997
390 Elizabeth, Vector is a company with very good analysts which specializes in bioJohn Metcalf-9/23/1997
389 >>>Vector Securities downgrades<<<< Of course -- GILD is pStarlight-9/23/1997
388 Vector Securities downgrades Gilead from Buy to AttractiveTrey Yon-9/23/1997
387 I do! -:) I will prefer "sa vami". mzMiljenko Zuanic-9/23/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News